Ignite Creation Date:
2025-12-24 @ 2:11 PM
Ignite Modification Date:
2026-01-27 @ 10:59 PM
Study NCT ID:
NCT07213895
Status:
COMPLETED
Last Update Posted:
2025-10-09
First Post:
2025-10-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCL 25mg/5mg/1000mg Extended-Release Tablets Versus Trijardy® XR Extended Release Film Coated Tablets
Sponsor:
Humanis Saglık Anonim Sirketi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-05-21
Start Date Type:
ACTUAL
Primary Completion Date:
2025-09-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-09-18
Completion Date Type:
ACTUAL
First Submit Date:
2025-10-02
First Submit QC Date:
None
Study First Post Date:
2025-10-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-02
Last Update Post Date:
2025-10-09
Last Update Post Date Type:
ESTIMATED